Long-Term Effectiveness of Polymerized-Type I Collagen Intra-Articular Injections in Patients with Symptomatic Knee Osteoarthritis: Clinical and Radiographic Evaluation in a Cohort Study
Open Access
- 1 August 2020
- journal article
- research article
- Published by Wiley in Advances in Orthopedics
- Vol. 2020, 1-9
Abstract
Objective. Polymerized-type I collagen (polymerized-collagen) is a downregulator of inflammation and a tissue regenerator. The aim was to evaluate the effect of intra-articular injections (IAIs) of polymerized-collagen among patients with symptomatic knee osteoarthritis (OA) in delaying or preventing joint replacement surgery. Patients and Methods. This was a cohort study of 309 patients with knee OA. Patients with mild-to-moderate disease were treated weekly with IAIs of 2 mL of polymerized-collagen for six weeks (n = 309). Follow-up was for 6–60 months. The primary endpoints included the following determinations: (1) therapeutic effect; (2) survival from total knee replacement surgery (TKR); (3) Western Ontario and McMaster University Osteoarthritis Index (WOMAC) and pain (visual analogue scale, VAS). Clinical improvement was defined as a decrease in pain exceeding 20 mm on the VAS and the achievement of at least 20% improvement from baseline with respect to the WOMAC score. Radiographic analysis was performed at baseline and 60 months. The joint space width in the medial, lateral, and patellofemoral compartments was calculated. Results. Patients who received IAIs of polymerized-collagen had a statistically significant improvement in the primary criteria (). Kaplan–Meier survival analysis of the therapeutic effect demonstrated 98.8% survival at 60 months with TKR as the endpoint. There was no significant reduction in joint space in any compartment based on the analyzed radiographs. No serious adverse events were recorded. Conclusion. Polymerized-collagen increased the time to TKR by at least 60 months, modifying the disease course, improving functional disability, and decreasing pain.
Keywords
This publication has 45 references indexed in Scilit:
- Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretationsTherapeutic Advances in Musculoskeletal Disease, 2013
- Hyaluronic Acid in the Treatment of Knee OsteoarthritisBioDrugs, 2012
- Polymerized-Type I Collagen Downregulates Inflammation and Improves Clinical Outcomes in Patients with Symptomatic Knee Osteoarthritis Following Arthroscopic Lavage: A Randomized, Double-Blind, and Placebo-Controlled Clinical TrialThe Scientific World Journal, 2012
- Polymerized-Type I Collagen Induces Upregulation of Foxp3-Expressing CD4 Regulatory T Cells and Downregulation of IL-17-Producing CD4T Cells (Th17) Cells in Collagen-Induced ArthritisJournal of Immunology Research, 2011
- Summary and recommendations of the OARSI FDA osteoarthritis Assessment of Structural Change Working GroupOsteoarthritis and Cartilage, 2011
- Effect of polymerized‐type I collagen in knee osteoarthritis. II. In vivo studyEuropean Journal of Clinical Investigation, 2009
- Effect of polymerized‐type I collagen in knee osteoarthritis. I. In vitro studyEuropean Journal of Clinical Investigation, 2009
- Cellular and humoral responses to collagen–polyvinylpyrrolidone administered during short and long periods in humansCanadian Journal of Physiology and Pharmacology, 2003
- Collagen‐PVP Decreases Collagen Turnover in Synovial Tissue Cultures from Rheumatoid Arthritis PatientsAnnals of the New York Academy of Sciences, 1999
- Development of criteria for the classification and reporting of osteoarthritis: Classification of osteoarthritis of the kneeArthritis & Rheumatism, 1986